Doxorubicin and trabectedin in leiomyosarcoma: pioneering a new era of smart combinations in soft tissue sarcomas

Tarek Assi; Axel Le Cesne

doi:10.1080/14796694.2025.2463881

Doxorubicin and trabectedin in leiomyosarcoma: pioneering a new era of smart combinations in soft tissue sarcomas

Tarek Assi, Axel Le Cesne

Résultats de recherche: Contribution à un journal › Editorial

langue originale	Anglais
Pages (de - à)	879-882
Nombre de pages	4
journal	Future Oncology
Volume	21
Numéro de publication	8
Les DOIs	https://doi.org/10.1080/14796694.2025.2463881
état	Publié - 1 janv. 2025

Accès au document

10.1080/14796694.2025.2463881

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{2255c1b5033b46e9a52f9aaa1895e398,

title = "Doxorubicin and trabectedin in leiomyosarcoma: pioneering a new era of smart combinations in soft tissue sarcomas",

keywords = "Sarcoma, chemotherapy, doxorubicin, leiomyosarcoma, metastasis, standard of care, trabectedin",

author = "Tarek Assi and {Le Cesne}, Axel",

year = "2025",

month = jan,

day = "1",

doi = "10.1080/14796694.2025.2463881",

language = "English",

volume = "21",

pages = "879--882",

journal = "Future Oncology",

issn = "1479-6694",

number = "8",

}

TY - JOUR

T1 - Doxorubicin and trabectedin in leiomyosarcoma

T2 - pioneering a new era of smart combinations in soft tissue sarcomas

AU - Assi, Tarek

AU - Le Cesne, Axel

PY - 2025/1/1

Y1 - 2025/1/1

KW - Sarcoma

KW - chemotherapy

KW - doxorubicin

KW - leiomyosarcoma

KW - metastasis

KW - standard of care

KW - trabectedin

UR - http://www.scopus.com/inward/record.url?scp=85217156835&partnerID=8YFLogxK

U2 - 10.1080/14796694.2025.2463881

DO - 10.1080/14796694.2025.2463881

M3 - Editorial

AN - SCOPUS:85217156835

SN - 1479-6694

VL - 21

SP - 879

EP - 882

JO - Future Oncology

JF - Future Oncology

IS - 8

ER -